KSA Capital Management’s Allergan plc AGN Stock Holding History

KSA Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,000	Closed	-$1.16M	–	37
2016 Q2	$1.16M	Buy	+5,000	New	+$1.15M	0.28%	23

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

KSA Capital Management's AGN Position: Q1 2018 in Review

KSA Capital Management sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,000 shares — an estimated $327K sold.

KSA Capital Management first reported a position in AGN in Q2 2016 and held it in 7 quarters. The position peaked at $1.62M in Q2 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

KSA Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
KSA Capital Management sold 2,000 Allergan plc shares in Q1 2018, an estimated $327K.
KSA Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
KSA Capital Management's Allergan plc position peaked at $1.62M in Q2 2016.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on KSA Capital Management's 13F filing for Q1 2018.